PortfoliosLab logoPortfoliosLab logo
FHLC vs. GERM
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

FHLC vs. GERM - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Fidelity MSCI Health Care Index ETF (FHLC) and Amplify Treatments, Testing and Advancements ETF (GERM). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


FHLC

1D
0.82%
1M
1.50%
YTD
-3.90%
6M
-4.11%
1Y
14.43%
3Y*
6.14%
5Y*
4.50%
10Y*
9.14%

GERM

1D
0.00%
1M
0.00%
YTD
0.00%
6M
0.00%
1Y
0.00%
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

FHLC vs. GERM - Yearly Performance Comparison


2026 (YTD)20252024
FHLC
Fidelity MSCI Health Care Index ETF
-3.90%15.42%-9.19%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%

FHLC vs. GERM - Sectors Allocation Comparison


Sectors
FHLC
GERM

Healthcare

99.6%
99.3%

Financial Services

0.1%
0.4%

Technology

0.0%

-

Industrials

0.0%

-

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Real Estate

-

-

Utilities

-

-

Healthcare

FHLC
99.6%
GERM
99.3%

Financial Services

FHLC
0.1%
GERM
0.4%

Technology

FHLC
0.0%
GERM

-

Industrials

FHLC
0.0%
GERM

-

Basic Materials

FHLC

-

GERM

-

Communication Services

FHLC

-

GERM

-

Consumer Cyclical

FHLC

-

GERM

-

Consumer Defensive

FHLC

-

GERM

-

Energy

FHLC

-

GERM

-

Real Estate

FHLC

-

GERM

-

Utilities

FHLC

-

GERM

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

FHLC vs. GERM — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

FHLC
FHLC Risk / Return Rank: 2727
Overall Rank
FHLC Sharpe Ratio Rank: 2727
Sharpe Ratio Rank
FHLC Sortino Ratio Rank: 2929
Sortino Ratio Rank
FHLC Omega Ratio Rank: 2626
Omega Ratio Rank
FHLC Calmar Ratio Rank: 2828
Calmar Ratio Rank
FHLC Martin Ratio Rank: 2626
Martin Ratio Rank

GERM
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

FHLC vs. GERM - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Fidelity MSCI Health Care Index ETF (FHLC) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


FHLCGERMDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.18

Calmar ratioReturn relative to maximum drawdown

1.40

Martin ratioReturn relative to average drawdown

3.52

FHLC vs. GERM - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


FHLCGERMDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

1.01

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.30

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.55

Sharpe Ratio (All Time)

Calculated using the full available price history

0.61

Drawdowns

FHLC vs. GERM - Drawdown Comparison

The maximum FHLC drawdown since its inception was -28.76%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for FHLC and GERM.


Loading charts...

Drawdown Indicators


FHLCGERMDifference

Max Drawdown

Largest peak-to-trough decline

-28.76%

0.00%

-28.76%

Max Drawdown (1Y)

Largest decline over 1 year

-10.38%

0.00%

-10.38%

Max Drawdown (3Y)

Largest decline over 3 years

-16.87%

Max Drawdown (5Y)

Largest decline over 5 years

-17.73%

Max Drawdown (10Y)

Largest decline over 10 years

-28.76%

Current Drawdown

Current decline from peak

-6.96%

0.00%

-6.96%

Average Drawdown

Average peak-to-trough decline

-5.19%

0.00%

-5.19%

Ulcer Index

Depth and duration of drawdowns from previous peaks

4.11%

0.00%

+4.11%

Volatility

FHLC vs. GERM - Volatility Comparison

Fidelity MSCI Health Care Index ETF (FHLC) has a higher volatility of 4.05% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that FHLC's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


FHLCGERMDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.05%

0.00%

+4.05%

Volatility (6M)

Calculated over the trailing 6-month period

10.11%

0.00%

+10.11%

Volatility (1Y)

Calculated over the trailing 1-year period

14.33%

0.00%

+14.33%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

14.97%

0.00%

+14.97%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

16.81%

0.00%

+16.81%

FHLC vs. GERM - Expense Ratio Comparison

FHLC has a 0.08% expense ratio, which is lower than GERM's 0.68% expense ratio.


Dividends

FHLC vs. GERM - Dividend Comparison

FHLC's dividend yield for the trailing twelve months is around 1.43%, while GERM has not paid dividends to shareholders.


PositionTTM20252024202320222021202020192018201720162015
FHLC
Fidelity MSCI Health Care Index ETF
1.43%1.40%1.51%1.40%1.30%1.16%1.45%1.18%1.38%1.38%1.40%2.07%
GERM
Amplify Treatments, Testing and Advancements ETF
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


FHLC has higher volatility (4.05%) compared to GERM (0.00%). In terms of maximum drawdown, FHLC dropped -28.76% vs GERM's 0.00%.

On 1-year performance, FHLC leads with 14.43% vs 0.00% for GERM. On fees, FHLC is cheaper at 0.08% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 1-year period, FHLC has performed better with a 14.43% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

FHLC is cheaper with a 0.08% expense ratio, compared with 0.68% for GERM.

FHLC has the higher dividend yield at 1.43%, compared with 0.00% for GERM.

FHLC tracks MSCI USA IMI Health Care Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: Fidelity and Amplify. Their fees differ too: 0.08% for FHLC and 0.68% for GERM.

Portfolio Optimizer

Find the right allocation for FHLC and GERM

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer